ACADIA Pharmaceuticals Inc. (ACAD) PT Trimmed Slightly as RBC Flags Seasonal Biotech Headwinds [Yahoo! Finance]
ACADIA Pharmaceuticals Inc. (ACAD)
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-irhome
Company Research
Source: Yahoo! Finance
TheFly reported on April 7 that RBC Capital Markets revised its outlook on ACAD, lowering its price target from $30 to $29 while keeping an Outperform rating. The adjustment was included in a broader Biotech sector preview ahead of first-quarter results. The firm noted that seasonal pressures such as reimbursement adjustments, fewer operating days, and adverse weather conditions could weigh on near-term performance, particularly for newly launched and clinic-dependent products. However, it also highlighted that renewed merger and acquisition activity and greater clarity on limited impacts from pricing policy changes may help balance short-term volatility and support a constructive sector outlook. On the same day, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced the U.S. launch of Daybue Stix, an oral formulation of trofinetide now widely accessible for treating Rett syndrome in both adults and children aged two years and older. ACADIA Pharmaceuticals Inc. (ACAD) PT Trimmed Sli
Show less
Read more
Impact Snapshot
Event Time:
ACAD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACAD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACAD alerts
High impacting ACADIA Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
ACAD
News
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Acadia Pharmaceuticals to Participate at Upcoming Investor ConferencesBusiness Wire
- Ryan Reynolds and Willie Geist Talk Dads With Parkinson’s Disease [MSNBC.com]MSNBC.com
- Acadia Pharmaceuticals to Present Data at the 2026 American Academy of Neurology (AAN) Annual MeetingBusiness Wire
- Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026Business Wire
ACAD
Earnings
- 2/25/26 - Beat
ACAD
Sec Filings
- 4/28/26 - Form SCHEDULE
- 4/24/26 - Form ARS
- 4/24/26 - Form DEF
- ACAD's page on the SEC website